Rossi GR - Search Results

1

Complete protection against melanoma in absence of autoimmune depigmentation after rejection of melanoma cells expressing alpha(1,3)galactosyl epitopes.

Rossi GR, Unfer RC, Seregina T, Link CJ. Rossi GR, et al. Cancer Immunol Immunother. 2005 Oct;54(10):999-1009. doi: 10.1007/s00262-005-0667-4. Epub 2005 May 12. Cancer Immunol Immunother. 2005. PMID: 15889257 Free PMC article.

2

Effective treatment of preexisting melanoma with whole cell vaccines expressing alpha(1,3)-galactosyl epitopes.

Rossi GR, Mautino MR, Unfer RC, Seregina TM, Vahanian N, Link CJ. Rossi GR, et al. Cancer Res. 2005 Nov 15;65(22):10555-61. doi: 10.1158/0008-5472.CAN-05-0627. Cancer Res. 2005. PMID: 16288048

3

Allogeneic melanoma vaccine expressing alphaGal epitopes induces antitumor immunity to autologous antigens in mice without signs of toxicity.

Rossi GR, Mautino MR, Awwad DZ, Husske K, Lejukole H, Koenigsfeld M, Ramsey WJ, Vahanian N, Link CJ. Rossi GR, et al. J Immunother. 2008 Jul-Aug;31(6):545-54. doi: 10.1097/CJI.0b013e31817d2f45. J Immunother. 2008. PMID: 18528300

4

The αGal HyperAcute(®) Technology: enhancing immunogenicity of antiviral vaccines by exploiting the natural αGal-mediated zoonotic blockade.

Mandell RB, Flick R, Staplin WR, Kaniewski LD, Carzoli AK, Manuszak RP, Wang J, Rossi GR, Vahanian NN, Link CJ. Mandell RB, et al. Among authors: rossi gr. Zoonoses Public Health. 2009 Aug;56(6-7):391-406. doi: 10.1111/j.1863-2378.2008.01191.x. Zoonoses Public Health. 2009. PMID: 19486321

5

Algenpantucel-L immunotherapy in pancreatic adenocarcinoma.

Coveler AL, Rossi GR, Vahanian NN, Link C, Chiorean EG. Coveler AL, et al. Among authors: rossi gr. Immunotherapy. 2016 Feb;8(2):117-25. doi: 10.2217/imt.15.113. Epub 2016 Jan 20. Immunotherapy. 2016. PMID: 26787078 Review.

6

Phase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma.

Zakharia Y, McWilliams RR, Rixe O, Drabick J, Shaheen MF, Grossmann KF, Kolhe R, Pacholczyk R, Sadek R, Tennant LL, Smith CM, Kennedy EP, Link CJ Jr, Vahanian NN, Yu J, Shen SS, Brincks EL, Rossi GR, Munn D, Milhem M. Zakharia Y, et al. Among authors: rossi gr. J Immunother Cancer. 2021 Jun;9(6):e002057. doi: 10.1136/jitc-2020-002057. J Immunother Cancer. 2021. PMID: 34117113 Free PMC article. Clinical Trial.

7

Combination immunotherapy for high-risk resected and metastatic melanoma patients.

Riker AI, Rossi GR, Masih P, Alsfeld LC, Denham F, Tennant L, Ramsey WJ, Vahanian NN, Link CJ. Riker AI, et al. Among authors: rossi gr. Ochsner J. 2014 Summer;14(2):164-74. Ochsner J. 2014. PMID: 24940124 Free PMC article.

8

Pancreatic cancer: Update on immunotherapies and algenpantucel-L.

McCormick KA, Coveler AL, Rossi GR, Vahanian NN, Link C, Chiorean EG. McCormick KA, et al. Among authors: rossi gr. Hum Vaccin Immunother. 2016 Mar 3;12(3):563-75. doi: 10.1080/21645515.2015.1093264. Hum Vaccin Immunother. 2016. PMID: 26619245 Free PMC article. Review.

9

Cellular immunotherapy study of prostate cancer patients and resulting IgG responses to peptide epitopes predicted from prostate tumor-associated autoantigens.

Hemstreet GP 3rd, Rossi GR, Pisarev VM, Enke CA, Helfner L, Hauke RJ, Tennant L, Ramsey WJ, Vahanian NN, Link CJ. Hemstreet GP 3rd, et al. Among authors: rossi gr. J Immunother. 2013 Jan;36(1):57-65. doi: 10.1097/CJI.0b013e3182780abc. J Immunother. 2013. PMID: 23211622 Clinical Trial.

10

High-throughput fluorescent screening of transgenic animals: phenotyping and haplotyping.

Hellrung DJ, Rossi G, Link CJ. Hellrung DJ, et al. Cytometry A. 2006 Oct 1;69(10):1092-5. doi: 10.1002/cyto.a.20328. Cytometry A. 2006. PMID: 16998869 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

45 results

Search Page